Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYN321 in symptomatic knee osteoarthritis
NCT06989645Phase 2Completed
- Sponsor
- Synartro
- Start
- Aug 2025
- Primary completion
- Feb 2026
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SYN321 in knee osteoarthritis (OA), sponsored by Synartro. Started Aug 2025; status: completed.
02
Drugs
SYN321
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06989645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06989645.